These data support further investigation of metabolomics in larger samples of clinical AD as well as in those with preclinical disease for use as biomarkers.

Preguntar a la IA

Me gusta

Guardar

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Kaddurah‐Daouk et al. (Sun,) studied this question.

synapsesocial.com/papers/69df274ed85e58e37b7a1743 https://doi.org/https://doi.org/10.1016/j.jalz.2010.06.001

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Monoamine oxidase—I1974 · 314 citations
2Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)2000 · 11,048 citations
3SELECTIVE LOSS OF NEURONES OF ORIGIN OF ADRENERGIC PROJECTION TO CEREBRAL CORTEX (NUCLEUS LOCUS COERULEUS) IN SENILE DEMENTIA1981 · 331 citations
4A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease2009 · 91 citations
5Markers of dopamine metabolism in Parkinson's disease1992 · 83 citations

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Monoamine oxidase—I1974 · 314 citations
2Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)2000 · 11,048 citations
3SELECTIVE LOSS OF NEURONES OF ORIGIN OF ADRENERGIC PROJECTION TO CEREBRAL CORTEX (NUCLEUS LOCUS COERULEUS) IN SENILE DEMENTIA1981 · 331 citations
4A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease2009 · 91 citations
5Markers of dopamine metabolism in Parkinson's disease1992 · 83 citations